This content is from: Capital Markets

Japan: Toughening up

Tatsu Katayama, Ayako Kuyama and Jeffrey A Eagan of Anderson Mori & Tomotsune outline enhanced regulations regarding marketing of OTC derivatives and structured products in Japan

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial